Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

NCT01260350 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

292

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG: SOF
DRUG: RBV
DRUG: PEG
DRUG: LDV
DRUG: GS-9669
DRUG: LDV/SOF

Sponsor

Gilead Sciences